| Literature DB >> 2900981 |
A Palsdottir1, M Abrahamson, L Thorsteinsson, A Arnason, I Olafsson, A Grubb, O Jensson.
Abstract
Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disorder in which a cysteine proteinase inhibitor, cystatin C, is deposited as amyloid fibrils in the cerebral arteries of patients and leads to massive brain haemorrhage and death in young adults. A full length cystatin C cDNA probe revealed a mutation in the codon for leucine at position 68 which abolishes an Alu I restriction site in the cystatin C gene of HCCAA patients. The Alu I marker has been used to show that this mutation is transmitted only in affected members of all eight families investigated, and that the mutated cystatin C gene causes HCCAA.Entities:
Mesh:
Substances:
Year: 1988 PMID: 2900981 DOI: 10.1016/s0140-6736(88)90641-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321